Editorial
 BAN ON FDC DRUGS   
 Wednesday, September 19, 2018 
 In a decisive action to weed out irrational, unscientific and hazardous drugs from the country‚Äôs pharmaceutical market, the Union Health Ministry has banned the controversial 328 Fixed Dose Combination drugs with immediate effect in the country. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Sosei, Allergan voluntarily suspend clinical development of HTL0018318
17:00  [IST]NIH awards US$ 7.5 mn for international research programme to prevent & treat HIV infection in poor countries
16:00  [IST]Canon Medical System partners with ACTG to provide precision cancer medicine service in Japan
15:00  [IST]Amicus to pay US$ 100 mn to buy 10 gene therapy programmes in neurologic lysosomal storage disorders
14:00  [IST]EU grants marketing approval for Mylan & Fujifilm Kyowa Kirin Biologics' Hulio
13:00  [IST]Pfizer's 20vPnC candidate, PF-06482077 gets Breakthrough Therapy designation from US FDA
more news >>
TOP NEWS
08:00  [IST]Govt gets ready to amend rules to hold manufacturers accountable for faulty medical devices
08:00  [IST]MSPC witnesses increasing trend in registrations with 2.30 lakh registered pharmacists till date
08:00  [IST]USP Education-Hyderabad Institute offers QC, QA and R&D training for pharma professionals; new registrations to begin from October
08:00  [IST]Medical tech industry associations join hands to partner with Ayushman Bharat scheme
08:00  [IST]MCI nod to fill additional MBBS seats after completion of admission process puts KNRUHS in a fix
08:00  [IST]Registration, licensing process for blood products to go online from Sept 26; e-filing of application on Sugam portal made mandatory
more news >>
YESTERDAY'S NEWS
18:00  [IST]Leica Microsystems launches PROVIDO multidisciplinary microsurgery microscope
17:00  [IST]Singapore Airlines introduces THRUCOOL for temperature-sensitive pharmaceutical & healthcare shipments
16:45  [IST]BR Life SSNMC teams up with Brains Neurosciences Center of Excellence to expand its medical speciality
16:00  [IST]US FDA grants orphan drug status to OBI Pharma's OBI-3424 to treat ALL
15:00  [IST]NIH awards US$ 9.4 mn for behavioral research on OUD prevention & treatment
14:00  [IST]Lonza expands Ibex Solutions to offer complete product lifecycle management in one site
more news >>
INTERVIEW  
IT and AI impacting standards of Indian healthcare
Dilip_Jose.jpgDilip Jose, managing director & chief executing officer, Manipal Health Enterprises Pvt Ltd
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the central govt's decision to replace MCI with National Medical Commission boost the medical education scenario in the country?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
CPhI-WW-Banners-150X60-120618-anim-v2
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |